CarDS Lab at ACC ’22

We are excited about the science being presented by our team at ACC Scientific Sessions.

Catch CarDS Lab researchers presenting their work at these times:

National Patterns of Eligibility for And Utilization of FDA-Approved Weight-Loss Agents Among US Adults, 2015-2018

Patrick Christopher Demkowicz, Arash A. Nargesi, Rohan Khera

Apr. 2, 2022, 12:30 PM - 12:40 PM

U.S. Patterns of Drug Utilization And Prescription Fills For Proven Cardioprotective Anti-Hyperglycemic Agents

Arash Aghajani Nargesi, Callahan Clark, Mengni Liu, Lian Chen, Abraham Reddy, Samuel Amodeo, Evangelos K. Oikonomou, Marc Suchard, Kasia Lipska, Darren K. McGuire, Zhenqiu Lin, Silvio E. Inzucchi, Harlan M. Krumholz, Rohan Khera

Apr. 2, 2022, 1:00 PM - 1:10 PM

Personalizing The Therapeutic Benefit from Spironolactone In Heart Failure With Preserved Ejection Fraction Through Computational Phenomaps Of The TOPCAT Trial And Machine Learning

Evangelos K. Oikonomou, Marc Suchard, Rohan Khera

Apr. 3, 2022, 9:45 AM - 10:30 AM

Identification Of Heart Failure with Reduced Ejection Fraction From Hospitalization Discharge Summaries Using Natural Language Processing

Astrid Hengartner, Benjamin Rosand, Philip Adejumo, Lian Chen, Arash A. Nargesi, Rohan Khera

Apr. 3, 2022, 9:45 AM - 10:30 AM

National Patterns of Eligibility And Use Of Novel Lipid-Lowering Therapies In The United States

Miles Shen, Arash Aghajani Nargesi, Khurram Nasir, Rohan Khera

Apr. 3, 2022, 11:45 AM - 11:55 AM